These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30820764)

  • 1. Increased Risk of Hypertension in Young Adults in Southwest China: Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Li D; Zeng X; Huang Y; Lei H; Li G; Zhang N; Huang W
    Curr Hypertens Rep; 2019 Feb; 21(3):21. PubMed ID: 30820764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
    Circulation; 2018 Jan; 137(2):109-118. PubMed ID: 29133599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them.
    Jiao Y; Sun Z; Xie Y; Zheng J; Li Z; Guo X; Dai Y; Zheng L; Sun Y
    BMC Cardiovasc Disord; 2020 May; 20(1):237. PubMed ID: 32429909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the European and American guidelines on hypertension prevalence, treatment, and cardiometabolic goals.
    Gijón-Conde T; Sánchez-Martínez M; Graciani A; Cruz JJ; López-García E; Ortolá R; Rodríguez-Artalejo F; Banegas JR
    J Hypertens; 2019 Jul; 37(7):1393-1400. PubMed ID: 31145710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the 2017 ACC/AHA guideline on the prevalence of elevated blood pressure and hypertension: a cross-sectional analysis of 10 799 individuals.
    Alyabsi M; Gaid R; Alqunaibet A; Alaskar A; Mahmud A; Alghamdi J
    BMJ Open; 2020 Dec; 10(12):e041973. PubMed ID: 33384395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.
    Khera R; Lu Y; Lu J; Saxena A; Nasir K; Jiang L; Krumholz HM
    BMJ; 2018 Jul; 362():k2357. PubMed ID: 29997129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into blood pressure targets for universal coverage of hypertension services in Iran: the 2017 ACC/AHA versus JNC 8 hypertension guidelines.
    Mahdavi M; Parsaeian M; Mohajer B; Modirian M; Ahmadi N; Yoosefi M; Mehdipour P; Djalalinia S; Rezaei N; Haghshenas R; Pazhuheian F; Madadi Z; Sabooni M; Razi F; Samiee SM; Farzadfar F
    BMC Public Health; 2020 Mar; 20(1):347. PubMed ID: 32183754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Impact of the 2017 High Blood Pressure Guideline Beyond the United States: A Case Study of the People's Republic of China.
    Barszczyk A; Yang D; Wei J; Huang W; Feng ZP; Lee K; Luo H
    Am J Hypertens; 2020 Sep; 33(9):846-851. PubMed ID: 32521545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential epidemiological impact of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on the Chinese population: a cross-sectional study in rural areas of Liaoning Province.
    Dong Y; Sun Z; Li Z; Guo X; Sun G; Xie Y; Zheng J; Dai Y; Wang Y; Guo R; Zheng L; Sun Y
    BMJ Open; 2020 Sep; 10(9):e035900. PubMed ID: 32963064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline.
    Lee JH; Kim SH; Kang SH; Cho JH; Cho Y; Oh IY; Yoon CH; Lee HY; Youn TJ; Chae IH; Kim CH
    Sci Rep; 2018 Sep; 8(1):13155. PubMed ID: 30177714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
    Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
    J Am Coll Cardiol; 2018 Jan; 71(2):109-118. PubMed ID: 29146532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017.
    Mirzaei M; Mirzaei M; Mirzaei M; Bagheri B
    BMC Cardiovasc Disord; 2020 Aug; 20(1):372. PubMed ID: 32799819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese Physicians' Perspectives on the 2017 American College of Cardiology/American Heart Association Hypertension Guideline: A Mobile App-Based Survey.
    Ni Z; He J; Wang JG; Cao J; Yang Q; Wu B; Shaw RJ
    High Blood Press Cardiovasc Prev; 2019 Jun; 26(3):247-257. PubMed ID: 31201617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension management.
    Vaucher J; Marques-Vidal P; Waeber G; Vollenweider P
    Eur J Prev Cardiol; 2018 Jul; 25(10):1111-1113. PubMed ID: 29637794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline.
    Kibria GMA; Swasey K; Kc A; Mirbolouk M; Sakib MN; Sharmeen A; Chadni MJ; Stafford KA
    JAMA Netw Open; 2018 Jul; 1(3):e180606. PubMed ID: 30646022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hypertension among Bangladeshi adults using the 2017 ACC/AHA Hypertension Clinical Practice Guidelines and Joint National Committee 7 Guidelines.
    Islam JY; Zaman MM; Haq SA; Ahmed S; Al-Quadir Z
    J Hum Hypertens; 2018 Oct; 32(10):668-680. PubMed ID: 30026561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 2017 ACC/AHA guideline on prevalence, awareness, treatment, control, and determinants of hypertension: a population-based cross-sectional study in southwest of Iran.
    Sadeghi F; Cheraghian B; Mohammadi Z; Sepanlou SG; Masoudi S; Rahimi Z; Danehchin L; Paridar Y; Abolnezhadian F; Noori M; Mard SA; Shayesteh AA; Poustchi H
    Popul Health Metr; 2021 May; 19(1):26. PubMed ID: 34034752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impacts of the New 2017 ACC/AHA Hypertension Guideline on the Prevalence of Brachial Hypertension and Its Concordance with Central Hypertension.
    Chuang SY; Chang HY; Cheng HM; Pan WH; Chen CH
    Am J Hypertens; 2019 Mar; 32(4):409-417. PubMed ID: 30657845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secular trends of hypertension prevalence based on 2017 ACC/AHA and 2018 Chinese hypertension guidelines: Results from CHNS data (1991-2015).
    Zheng L; Dai Y; Fu P; Yang T; Xie Y; Zheng J; Gao J; Niu T
    J Clin Hypertens (Greenwich); 2021 Jan; 23(1):28-34. PubMed ID: 32970919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension prevalence alteration in 92 815 nurses based on the new standard by 2017 ACC/AHA hypertension guideline: observational cross-sectional study from China.
    Zhao B; Li J; Liu J; Hao Y; Zhen Y; Feng D; Xu M; Chen X; Yang X; Zuo A; Jia R; Zhang R; Fan A; Wang Y; Yuan M; Tong L; Chen S; Cui J; Zhao M; Cui W
    BMJ Open; 2019 Aug; 9(8):e027201. PubMed ID: 31471431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.